Journal profile · Medicine-Cardiology and Cardiovascular Medicine

Cardiac Failure Review

ISSN 2057-7540 · eISSN 2057-7559 · Radcliffe Medical Media · United Kingdom

Cardiac Failure Review: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 12.2 (journal website); fully open access; APC charged, amount not published; median 72 days to acceptance (66 articles, last 24 months); 36 articles in 2025; indexed in ESCI and Scopus.

Impact factor12.2From the journal's website, latest value
CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine
Review time72 daysMedian, submission to acceptance · 66 articles, last 24 months · PubMed
APCCharged, amount not publishedFully open access
Acceptance—No reports yet
Articles per year362025 · OpenAlex count

Scope

Aims, scope and focus

Cardiac Failure Review is published by Radcliffe Medical Media and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors and Cardiac pacing and defibrillation studies, together about 50.5% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)

Cardiac Failure Review (CFR) is a Tri-Annual journal aimed at assisting heart failure specialists and cardiologists to stay abreast of key advances and opinion in the diagnosis, management and treatment of heart failure.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Cardiology and Cardiovascular Medicine

Editor-in-chief Andrew JSPublisher website

Editorial board by country: none in mainland China; most named United Kingdom 6, Italy 2, Australia 2, United States 1, Sweden 1 (15 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Heart Failure Treatment and ManagementMedicine25.3%
  2. Cardiovascular Function and Risk FactorsMedicine17.7%
  3. Cardiac pacing and defibrillation studiesMedicine7.5%
  4. Mechanical Circulatory Support DevicesEngineering5.5%
  5. Cardiac Structural Anomalies and RepairMedicine5.5%
  6. Diabetes Treatment and ManagementMedicine4.4%
  7. Cardiac Imaging and DiagnosticsMedicine3.4%
  8. Cardiac Valve Diseases and TreatmentsMedicine3.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorCardiac & Cardiovascular SystemsZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorCardiac & Cardiovascular SystemsZone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
12.2Publisher website ·
CiteScore 2026-06
10LetPub ·
SJR 2026-06
2.27LetPub ·
SNIP 2026-06
2.4LetPub ·
h-index
43OpenAlex ·
i10-index
177OpenAlex ·
2-year mean citedness
4.84OpenAlex ·
Self-citation rate
2.5%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
33LetPub ·
Articles per year (publisher)
4Publisher website ·

Articles by year OpenAlex count · 328 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026333313
20253636200
20242020218
20231414870
20223636752
20212323436

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

72 daysMedian, submission to acceptance · P25–P75 46 days – 106 days

Acceptance to online
median 97 days (66 articles)
Submission to online
median 177 days
Sample
66 articles with submission and acceptance dates (71 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 9 weeksLetPub ·
Submission to first decision
35 daysPublisher website ·
Submission to final decision
63 daysPublisher website ·
Submission to publication (journal-reported)
about 12 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJGBP 1,750YesCC BY, CC BY-NC
OpenAlexGBP 1,750——
LetPubGBP 1,750Yes—
Publisher websiteGBP 1,750 / EUR 2,069 / USD 2,299 / GBP 3,300 / EUR 3,816 / USD 4,426 / GBP 3,900 / EUR 4,508 / USD 5,232 / GBP 2,600 / EUR 3,005 / USD 3,488 / GBP 1,500 / EUR 1,770 / USD 1,970 / GBP 2,000 / EUR 2,420 / USD 2,550——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare1 items from the author guidelines
Keywords
3–7
Publisher website · model-extracted, each line checked against the text
Article types accepted6, with length limits
  1. case reportve services available. Submission types Case Reports: 1,500 - 3,000 words excl abstract & refs. Max. 50 references. Editorial: 1500 -main text ≤ 3,000 words
  2. editorialcl abstract & refs. Max. 50 references. Editorial: 1500 - 2000 words excl abstract & refs. Max. 15 references. Editorials are bymain text ≤ 2,000 words
  3. letterexcl abstract & ref. Max. 20 references Letter: 1500 words. Max 10 references. Review Article: 2,500 – 5,000 words excmain text ≤ 1,500 words
  4. opinionitorials are by invitation only. Expert Opinion: 1,500 – 2500 words excl abstract & ref. Max. 20 references Letter: 1500 words.main text ≤ 2,500 words
  5. original researchxcl abstract & ref. Max. 80 references. Original Research: 2,500 – 5,000 words excl abstract & Ref. Max 100 references. Articles submittedmain text ≤ 5,000 words
  6. review articleLetter: 1500 words. Max 10 references. Review Article: 2,500 – 5,000 words excl abstract & ref. Max. 80 references. Original Research:main text ≤ 5,000 words
Publisher website

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Radcliffe Medical Media
Country or region
United Kingdom
Language
English
ISSN
2057-7540
Electronic ISSN
2057-7559
Society / sponsor
Italian Heart Failure Association
Official links

FAQ

Frequently asked questions about Cardiac Failure Review

What CAS zone is Cardiac Failure Review in?

In the 2025 upgraded edition of the CAS Journal Ranking, Cardiac Failure Review is in Zone 2 of Medicine, and in Zone 3 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Cardiac Failure Review?

The journal's website gives an impact factor of 12.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 10, h-index 43.

How long does peer review take at Cardiac Failure Review?

Based on the dates recorded on 66 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 72 days (interquartile range 46–106 days); authors report an average review time of about 9 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Cardiac Failure Review based?

Of the 15 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (6), Italy (2) and Australia (2). Counted from the institutions listed on the board page; for reference only.

Which databases index Cardiac Failure Review?

According to LetPub and DOAJ records, Cardiac Failure Review is indexed in ESCI, Scopus and DOAJ.

Is Cardiac Failure Review open access, and what is the APC?

Cardiac Failure Review is a fully open-access journal. APC charged, amount not published.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .